Detalhe da pesquisa
1.
Building a network of TP53 and IGHV testing reference centers across Spain: the Red53 initiative.
Ann Hematol
; 100(3): 825-830, 2021 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-33409623
2.
COVID-19 in patients with CLL: improved survival outcomes and update on management strategies.
Blood
; 138(18): 1768-1773, 2021 11 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34297826
3.
Exome sequencing reveals heterogeneous clonal dynamics in donor cell myeloid neoplasms after stem cell transplantation.
Haematologica
; 105(11): 2655-2658, 2020 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33131255
4.
First-line treatment with rituximab-hyperCVAD alternating with rituximab-methotrexate-cytarabine and followed by consolidation with 90Y-ibritumomab-tiuxetan in patients with mantle cell lymphoma. Results of a multicenter, phase 2 pilot trial from the GELTAMO group.
Haematologica
; 98(10): 1563-70, 2013 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-23753021
5.
Real-World Evidence on the Clinical Characteristics and Management of Patients with Chronic Lymphocytic Leukemia in Spain Using Natural Language Processing: The SRealCLL Study.
Cancers (Basel)
; 15(16)2023 Aug 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37627075
6.
Incidence and prognostic impact of secondary cytogenetic aberrations in a series of 145 patients with mantle cell lymphoma.
Genes Chromosomes Cancer
; 49(5): 439-51, 2010 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-20143418
7.
Immunological and genetic kinetics from diagnosis to clinical progression in chronic lymphocytic leukemia.
Biomark Res
; 9(1): 37, 2021 May 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-34016160
8.
COVID-19 severity and mortality in patients with chronic lymphocytic leukemia: a joint study by ERIC, the European Research Initiative on CLL, and CLL Campus.
Leukemia
; 34(9): 2354-2363, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32647324
9.
Minimal residual disease in chronic lymphocytic leukaemia. / Enfermedad residual mínima en la leucemia linfática crónica.
Med Clin (Barc)
; 150(4): 144-149, 2018 02 23.
Artigo
em Inglês, Espanhol
| MEDLINE | ID: mdl-28864095
10.
Prostatic-Like Syndrome in a Woman with Chronic Lymphocytic Leukemia: Sequential Kinase Inhibitor Therapy.
Case Rep Hematol
; 2017: 3869020, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28751992
11.
Current and emerging treatment options for hairy cell leukemia.
Onco Targets Ther
; 8: 2147-56, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26316784
12.
Vascular endothelial growth factor A (VEGFA) gene polymorphisms have an impact on survival in a subgroup of indolent patients with chronic lymphocytic leukemia.
PLoS One
; 9(6): e101063, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24971577
13.
[Economic evaluation of rituximab added to fludarabine plus cyclophosphamide versus fludarabine plus cyclophosphamide for the treatment of chronic lymphocytic leukemia]. / Evaluación económica de rituximab en combinación con fludarabina y ciclofosfamida en comparación con fludarabina y ciclofosfamida en el tratamiento de la leucemia linfática crónica.
Gac Sanit
; 25(4): 274-81, 2011.
Artigo
em Espanhol
| MEDLINE | ID: mdl-21664727
14.
CD154 expression triggered by purine analogues in vitro: Correlation with treatment response and autoimmune events in chronic lymphocytic leukemia.
Exp Hematol
; 38(3): 165-73, 2010 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-20026377
15.
Rituximab, fludarabine, cyclophosphamide, and mitoxantrone: a new, highly active chemoimmunotherapy regimen for chronic lymphocytic leukemia.
J Clin Oncol
; 27(27): 4578-84, 2009 Sep 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-19704063
16.
Enfermedad residual mínima en la leucemia linfática crónica / Minimal residual disease in chronic lymphocytic leukaemia
Med. clín (Ed. impr.)
; 150(4): 144-149, feb. 2018. tab
Artigo
em Espanhol
| IBECS (Espanha) | ID: ibc-170611
17.
Evaluación económica de rituximab en combinación con fludarabinay ciclofosfamida en comparación con fludarabina y ciclofosfamida enel tratamiento de la leucemia linfática crónica / Economic evaluation of rituximab added to fludarabine plus cyclophosphamide versus fludarabine plus cyclophosphamide for the treatment of chronic lymphocytic leukemia
Gac. sanit. (Barc., Ed. impr.)
; 25(4): 274-281, jul.-ago. 2011. ilus, tab
Artigo
em Espanhol
| IBECS (Espanha) | ID: ibc-93230